| 000 | 01741 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512091848.0 | ||
| 264 | 0 | _c19730619 | |
| 008 | 197306s 0 0 eng d | ||
| 022 | _a0023-2173 | ||
| 024 | 7 |
_a10.1007/BF01467813 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGleichmann, E | |
| 245 | 0 | 0 |
_aImmunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review. _h[electronic resource] |
| 260 |
_bKlinische Wochenschrift _cMar 1973 |
||
| 300 |
_a260-5 concl p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnimals, Newborn _ximmunology |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xadverse effects |
| 650 | 0 | 4 |
_aAntimetabolites _xadministration & dosage |
| 650 | 0 | 4 |
_aAzathioprine _xadverse effects |
| 650 | 0 | 4 |
_aCarcinogens _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aGraft vs Host Reaction |
| 650 | 0 | 4 | _aHistocompatibility Antigens |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aLymphoma _ximmunology |
| 650 | 0 | 4 |
_aMercaptopurine _xadverse effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred NZB |
| 650 | 0 | 4 |
_aOncogenic Viruses _ximmunology |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aThymectomy |
| 700 | 1 | _aGleichmann, H | |
| 773 | 0 |
_tKlinische Wochenschrift _gvol. 51 _gno. 6 _gp. 260-5 concl |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01467813 _zAvailable from publisher's website |
| 999 |
_c4150102 _d4150102 |
||